Clinical Trial Update: A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of SGC001 in patients with anterior wall acute myocardial infarction; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Wall Myocardial Infarction
• Myocardial Infarction

Drugs mentioned

• SGC001

Snippet

Sponsor: Beijing Sungen Biomedical Technology Co., Ltd | Conditions: Anterior Myocardial Infarction | Phase 2 | Status: NOT_YET_RECRUITING